Kinetic Control Training Versus Core Stability Exercises on Proprioception and Spatiotemporal Gait Parameters in Chronic Non-specific Low Back Pain (CNSLBP)
1 juillet 2026 mis à jour par: Ola Adel Abd Elrazik Ibrahem, Cairo University
This study will be conducted to comapre between kinetic control training versus core stability exercises on proprioception and spatiotemporal gait parameters in chronic non-specific low back pain.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Description détaillée
Chronic nonspecific low back pain (CNSLBP) represents a significant public health problem and an economic burden to employers.
It has become one of the most common problems in industrialized societies; it can affect 80% of people and has become the most common cause of functional limitation in individuals younger than 35 years.
Neuromuscular impairments and deficits are a primary contributor to the inception and chronicity of Low back pain with the psychological and social competes.
Specific-oriented retraining has a major effect in modulating biopsychosocial competes severity and peculiarity and crucial for controlling chronic Low back pain.
Interventions targeting neuromuscular impairments of the movement system are the most promising movement control concepts in these Low back pain treatment approaches.Kinetic Control Training (KCT), which focuses on movement control and muscle coordination, has emerged as a potential intervention for addressing the underlying motor control deficits associated with CNSLBP.
Exercises in managing CNSLBP.
For instance, a randomized controlled trial demonstrated that core stability training significantly improved back muscle strength and reduced pain intensity in young adults with chronic non-specific low back pain.
To the best of authors' knowledge, the effect of kinetic control versus core stability training on the spatiotemporal parameters of the gait has not been investigated yet.
So this study will be conducted to investigate this point.
Type d'étude
Interventionnel
Inscription (Estimé)
60
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: ola Adel, phd
- Numéro de téléphone: 01207003453
- E-mail: adelola191@gmail.com
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
- Subjects from both sexes diagnosed with chronic non-specific low back pain with uncontrolled movement related to kinetic control concept
- aging range from 18-45 years
- Pain provoked by movement.
- Pain for at least 3 months
- Pain with sufficient intensity (equal to or greater than 4 points on VAS).
Exclusion Criteria:
- History of previous spinal surgery.
- Patients with lumbar spine diseases (for example, disc prolapse or spondylolisthesis).
- Patients with abnormal neurological signs in lower extremities, radicular pain in the lower limb, hip arthrosis, congenital musculoskeletal deformity, female patients with pelvic lesions, and pregnant females.
- Red flag signs include unwanted weight loss, less than three months of symptom persistence, malignancies of the spine, spinal instability due to structural cause, for example: ligamentous sprain or spondylolisthesis.
- Gynaecological problems in females that may cause low back pain include coccydynia and hysterotomy
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Kinetic control group
Twenty patients will receive kinetic control training with conventional physical therapy three times a week for 8 weeks
|
Each patient in the group will be received kinetic control retraining with conventional physical therapy.
For each movement direction, specific control tests will be conducted.
The direction and site of the uncontrolled movement will be evaluated using special tests in accordance with the pain history of the patient.
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
|
|
Expérimental: Core stability exercises group
Twenty patients will receive core stability exercises with conventional physical therapy three times a week for 8 weeks
|
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
Core stability exercises include curl up (head and shoulders lifting), bridging exercise with leg elevation, and quadruped with arm and leg lift will be performed with maintaining the lumbar spine neutral.
each patient in that group will be received core stability exercises with conventional physical therapy,
|
|
Comparateur actif: Conventional physical therapy exercise
twenty patients will receive conventional physical therapy three times a week for 8 weeks
|
conventional physical therapy includes Trans-cutaneous electric Nerve Stimulation (TENS), Heat by hot packs
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
lumber repositioning error (lumbar proprioception)
Délai: up to 8 weeks
|
The iPhone® application will be used to assess lumbar repositioning error.
It will be placed vertically, halfway between the anterior superior and PSIS, just above the iliac crest, and fastened with a belt.
The initial location and the inclination of the inclinometer were both fixed at 0°.
There was a 0 to 30° range of motion (ROM).
The assessor gently guided the individual to a 30° flexion and instructed them to hold this posture for ten seconds.
After then, the participant actively went back to their starting location and subsequently did it three times.
|
up to 8 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
pain intensity
Délai: up to 8 weeks
|
visual analogue scale will be used to assess pain intensity.t
consists of a 100-mm line with descriptive anchors representing extremes at each end, such as "no pain" and "worst pain imaginable.
|
up to 8 weeks
|
|
gait speed
Délai: up to eight weeks
|
Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
normal, healthy gait speed for adults is generally between 1.0 m/s to 1.5 m/s.
|
up to eight weeks
|
|
cadence
Délai: up to eight weeks
|
Cadence in gait is the rate at which steps are taken during locomotion, measured as steps per minute.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
A healthy adult's normal walking cadence typically ranges between 100 to 120 steps per minute.
|
up to eight weeks
|
|
stride and step time
Délai: up to eight weeks
|
Stride time is the total time taken to complete one full gait cycle.
Step time is the time it takes to complete a single step.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
Normal walking gait for a healthy adult at a comfortable pace typically features a stride time of about 1.15 seconds and a step time of about 0.5 to 0.6 seconds
|
up to eight weeks
|
|
stride and step length
Délai: up to eight weeks
|
Step length is the distance between the placement of one foot and the next placement of the opposite foot.
Stride length, conversely, covers the distance of two consecutive steps.
Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
A normal walking step length 58 to 76 cm.
A stride length averaging 52 to 60 inches.
|
up to eight weeks
|
|
COG vertical displacement
Délai: up to eight weeks
|
Vertical displacement of the Center of Gravity (CoG) typically refers to the rhythmic, up-and-down movement of the body's mass center during the human gait cycle.
In a normal walking step, this vertical movement ranges to about 5 cm, helping conserve overall energy and maintain smooth motion.Using Kinovea (an open-source software) (version 0.9.5), a freeware motion analysis software will be used to retrieve all of the videos from the Sony Video camera.
|
up to eight weeks
|
|
life disability
Délai: up to eight weeks
|
The WHOQOL-BREF will be used to assess life disability.
it is a 26-item survey evaluating Quality of Life (QoL) across four domains: Physical, Psychological, Social Relationships, and Environment.
Higher scores in each domain indicate a better perception of QoL
|
up to eight weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
10 juillet 2026
Achèvement primaire (Estimé)
1 mai 2027
Achèvement de l'étude (Estimé)
1 mai 2027
Dates d'inscription aux études
Première soumission
8 juin 2026
Première soumission répondant aux critères de contrôle qualité
1 juillet 2026
Première publication (Réel)
6 juillet 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
6 juillet 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
1 juillet 2026
Dernière vérification
1 juillet 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- P.T.REC/012/006359
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .